Now accepting Telehealth appointments. Schedule a virtual visit.

Neurostimulation for Treatment Resistant Depression

Neurostimulation delivers electrical pulses to the brain to treat patients experiencing depression, Parkinson's, chronic pain, movement disorders and many more. Over the few decades, advancements in technology and neuroscience has produced positive techniques beyond invasive treatments like electroconvulsive therapy that could be commonplace treatments for millions of individuals who suffer from depression and other disorders. 

Transcranial Magnetic Stimulation (TMS) is a noninvasive form of neurostimulation that is different from other invasive and deep brain stimulations, which require devices to be implanted into the patient's body. This treatment is the most readily available stimulation method and has clearance from the FDA for depression. Advances from the typical 10 Hz of magnetic stimulation at the dorsalateral prefrontal cortex have showed promising results. However, a newer version of the treatment offers a more tailored approach accounting for the individual's unique neuroanatomy. Intermittent Theta Burst Stimulation (iTBS) is a form of rTMS that delivers more rapid pulses and produces the same results in half the time. iTBS has shown to have stronger and faster positive results than the original protocol. 

If you think iTBS can benefit you, give us a call for more information or visit the "About Practice" tab. 

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).